X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1349) 1349
Publication (272) 272
Book Chapter (12) 12
Book Review (12) 12
Conference Proceeding (1) 1
Data Set (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (1014) 1014
index medicus (896) 896
humans (710) 710
sphingosine - analogs & derivatives (649) 649
lysophospholipids - metabolism (514) 514
mice (492) 492
male (399) 399
sphingosine - metabolism (344) 344
lipids (328) 328
sphingosine 1-phosphate (324) 324
lysophospholipids - pharmacology (309) 309
female (298) 298
sphingosine (279) 279
biochemistry & molecular biology (274) 274
sphingosine-1-phosphate (273) 273
rats (252) 252
cell biology (250) 250
lysophosphatidic acid (249) 249
phosphates (224) 224
signal transduction (213) 213
sphingosine - pharmacology (197) 197
mice, inbred c57bl (194) 194
article (179) 179
pharmacology & pharmacy (179) 179
lysophospholipids (176) 176
cells, cultured (174) 174
apoptosis (172) 172
activation (160) 160
receptors, lysosphingolipid - metabolism (159) 159
inflammation (152) 152
physiological aspects (147) 147
analysis (145) 145
signal transduction - drug effects (143) 143
cells (139) 139
expression (136) 136
immunology (131) 131
cancer (125) 125
disease models, animal (123) 123
research (119) 119
phosphotransferases - metabolism (118) 118
neurosciences (113) 113
oncology (111) 111
lysophospholipids - blood (109) 109
lysophospholipids - physiology (107) 107
fty720 (106) 106
protein-coupled receptor (105) 105
dose-response relationship, drug (104) 104
in-vivo (103) 103
proteins (100) 100
rodents (99) 99
lysophospholipids - administration & dosage (95) 95
kinases (92) 92
receptor (92) 92
phospholipids (90) 90
physiology (90) 90
research article (89) 89
health aspects (88) 88
mice, knockout (87) 87
rats, sprague-dawley (87) 87
receptors (87) 87
sphingosine kinase (87) 87
fingolimod hydrochloride (86) 86
multidisciplinary sciences (84) 84
cell line (83) 83
medicine, research & experimental (83) 83
apoptosis - drug effects (81) 81
cell line, tumor (79) 79
receptors, lysophosphatidic acid - metabolism (79) 79
phosphorylation (76) 76
metabolism (75) 75
endothelial-cells (73) 73
enzymes (73) 73
sphingolipids (73) 73
lpa (71) 71
gene expression (70) 70
rats, wistar (70) 70
sphingosine - physiology (70) 70
lymphocyte egress (69) 69
time factors (69) 69
angiogenesis (66) 66
ceramide (66) 66
medicine (66) 66
middle aged (66) 66
propylene glycols - pharmacology (66) 66
biophysics (64) 64
in-vitro (63) 63
mice, inbred balb c (63) 63
migration (63) 63
inhibition (62) 62
s1p (62) 62
signal transduction - physiology (62) 62
abridged index medicus (60) 60
adult (58) 58
science (58) 58
cell proliferation (57) 57
mass spectrometry (57) 57
care and treatment (56) 56
receptors, lysosphingolipid - antagonists & inhibitors (56) 56
sphingosine - administration & dosage (56) 56
sphingosine - blood (56) 56
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Respiratory Cell and Molecular Biology, ISSN 1044-1549, 05/2010, Volume 42, Issue 5, pp. 572 - 577
Journal Article
Journal of Lipid Research, ISSN 0022-2275, 2017, Volume 58, Issue 4, pp. 636 - 648
The pathophysiology of human keratoconus (KC), a bilateral progressive corneal disease leading to protrusion of the cornea, stromal thinning, and scarring, is... 
Lipidomics | Cornea | Transforming growth factor-β | RETINAL DEGENERATION | FIBROSIS | OXIDATIVE STRESS | cornea | BIOCHEMISTRY & MOLECULAR BIOLOGY | PENETRATING KERATOPLASTY | SPHINGOSINE 1-PHOSPHATE | CERAMIDE SYNTHASES | CELL-DEATH | transforming growth factor-beta | IN-VITRO MODEL | THERAPEUTIC TARGETS | LIGHT-INDUCED DEGENERATION | lipidomics | Lysophospholipids - administration & dosage | Transforming Growth Factor beta1 - administration & dosage | Fibroblasts - physiology | Humans | Transforming Growth Factor beta2 - administration & dosage | Sphingosine - administration & dosage | Keratoconus - genetics | Lysophospholipids - biosynthesis | Cornea - pathology | Keratoconus - pathology | Transforming Growth Factor beta3 - administration & dosage | Fibroblasts - metabolism | Fingolimod Hydrochloride - administration & dosage | Ceramides - administration & dosage | Cell Line | Signal Transduction | RNA, Messenger - genetics | Sphingolipids - metabolism | Sphingolipids - isolation & purification | Ceramides - genetics | Cornea - metabolism | Sphingosine - analogs & derivatives | Sphingolipids - genetics | Sphingosine - biosynthesis | Fibroblasts - drug effects | Collagen (type III) | Smooth muscle | mRNA | Sphingolipids | Sphingosine 1-phosphate | Signal transduction | Actin | Keratoconus | FTY720 | Isoforms | Fibroblasts | Ceramide | transforming growth factor-β
Journal Article
Journal Article
Clinica Chimica Acta, ISSN 0009-8981, 01/2013, Volume 415, pp. 74 - 80
Journal Article
Respiratory Research, ISSN 1465-9921, 11/2016, Volume 17, Issue 1, p. 146
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 09/2010, Volume 161, Issue 1, pp. 176 - 192
Journal Article
Journal of Dermatological Science, ISSN 0923-1811, 2013, Volume 71, Issue 1, pp. 29 - 36
Abstract Background It has been indicated that the sphingolipid sphingosine-1-phosphate (S1P) restrains the ability of dendritic cells to migrate to lymph... 
Dermatology | Psoriasis | Imiquimod | SCID mice | Sphingosine-1-phosphate | KERATINOCYTES | MONOCLONAL-ANTIBODY | SPHINGOSINE 1-PHOSPHATE | DERMATOLOGY | DENDRITIC CELL-MIGRATION | INHIBITION | IMMUNOPATHOGENESIS | SKIN | VULGARIS | EXPRESSION | T-CELLS | Lysophospholipids - administration & dosage | Skin - metabolism | Dermatologic Agents - administration & dosage | Humans | Administration, Cutaneous | Calcitriol - analogs & derivatives | Sphingosine - administration & dosage | Psoriasis - pathology | Time Factors | Lysophospholipids - pharmacology | Psoriasis - metabolism | Anti-Inflammatory Agents - administration & dosage | Female | Skin Transplantation | Receptors, Lysosphingolipid - metabolism | Skin - pathology | Dermatologic Agents - pharmacology | Disease Models, Animal | Betamethasone - pharmacology | Propylene Glycols - pharmacology | Psoriasis - drug therapy | Betamethasone - analogs & derivatives | Anti-Inflammatory Agents - pharmacology | Fingolimod Hydrochloride | Local Lymph Node Assay | Mice, SCID | Receptors, Lysosphingolipid - drug effects | Sphingosine - pharmacology | Keratinocytes - pathology | Sphingosine - analogs & derivatives | Animals | Keratinocytes - drug effects | Cell Differentiation - drug effects | Keratinocytes - metabolism | Propylene Glycols - administration & dosage | Calcitriol - pharmacology | Psoriasis - chemically induced | Cell Proliferation - drug effects | Mice | Mice, Inbred BALB C | Skin - drug effects | Aminoquinolines | Phosphates | Anti-inflammatory drugs | Dendritic cells | Analysis | Sphingosine | Drugstores | Lipids | Exhibitions | Models | Index Medicus
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2013, Volume 8, Issue 1, p. e55255
Novel classes of pain-relieving molecules are needed to fill the void between non-steroidal anti-inflammatory agents and narcotics. We have recently shown that... 
COLLAGEN-INDUCED ARTHRITIS | TUMOR-NECROSIS-FACTOR | MORPHINE ANTINOCICEPTIVE TOLERANCE | MULTIDISCIPLINARY SCIENCES | RAT SENSORY NEURONS | NF-KAPPA-B | HUMAN ENDOTHELIAL-CELLS | SPHINGOSINE-1-PHOSPHATE RECEPTOR | NERVE GROWTH-FACTOR | S1P ANTAGONIST | SPINAL CERAMIDE | Hyperalgesia - chemically induced | Lysophospholipids - administration & dosage | Lysophospholipids - metabolism | Receptors, Lysosphingolipid - antagonists & inhibitors | Hyperalgesia - metabolism | Neutrophils - immunology | Rats | Male | Polysaccharides - pharmacology | Sphingosine - pharmacology | Hyperalgesia - immunology | Sphingosine - analogs & derivatives | Animals | Sphingosine - administration & dosage | Carrageenan - pharmacology | Lysophospholipids - pharmacology | Polysaccharides - administration & dosage | Sphingosine - metabolism | Receptors, Lysosphingolipid - metabolism | Neutrophils - metabolism | Neutrophil Infiltration - drug effects | Carrageenan - administration & dosage | Phosphates | Carrageenin | Fluocinolone acetonide | Enantiomers | Drug approval | Sphingosine | Blocking antibodies | Arthritis | Kinases | Sphingosine 1-phosphate | Cell adhesion & migration | Signal transduction | Pain | Rodents | Animal tissues | Physiology | Nonsteroidal anti-inflammatory drugs | Edema | Sphingosine kinase | Pain perception | Antiinflammatory agents | Narcotics | Cytokines | Neutrophils | Blocking | Leukocytes (neutrophilic) | Inflammation | Injection | Bioavailability | Fucoidan | Medicine | Signaling | Inhibitors | Acids | FTY720 | Infiltration | Carrageenan | Laboratory animals
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 04/2011, Volume 17, Issue 8, pp. 2484 - 2492
Journal Article